Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -34.154% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. O=C1CCC(Cc2ccccc2)N1
b. CC(=O)C1=C(C)N(CC2CC2)C(=O)N[C@H]1c1cccs1
c. Cc1ccc(NC(=O)C2COc3ccccc3O2)cc1S(=O)(=O)N1CCOCC1
Answer: c. Cc1ccc(NC(=O)C2COc3ccccc3O2)cc1S(=O)(=O)N1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(NC(=O)C2COc3ccccc3O2)cc1S(=O)(=O)N1CCOCC1
Cc1ccc(NC(=O)C2COc3ccccc3O2)cc1S(=O)(=O)N1CCOCC1
N-(4-methyl-3-morpholin-4-ylsulfonylphenyl)-2,3-dihydro-1,4-benzodioxine-3-carboxamide